NEP INTERLONG News

Neptune Interlon (08329) announced its first quarter results. Profit attributable to shareholders of 19.3 million yuan increased 18.67% year over year

Neptune Interlon (08329) announced the first quarter results for the three months ended March 31, 2024. The group took...

Zhitong FinanceMay 27 06:07 ET

NEP INTERLONG: ABSTRACT OF THE FIRST QUARTERLY RESULTS FOR THE THREE MONTHS ENDED 31 MARCH 2024

Hong Kong Stock ExchangeMay 27 06:03 ET · Announcements

Neptune Interlon (08329.HK) will purchase medical devices from the Neptune Group

Gelonghui, May 7, 丨 Neptune Interlon (08329.HK) announced that the company and Neptune Biotech (the company's controlling shareholder and related party) entered into a 2024 framework agreement on May 7, 2024. Based on this, the Group will purchase medical devices from Haiwang Group to be sold on behalf of China.

Gelonghui FinanceMay 7 05:59 ET

We Think You Can Look Beyond Shenzhen Neptunus Interlong Bio-technique's (HKG:8329) Lackluster Earnings

Simply Wall StApr 18 20:26 ET

NEP INTERLONG: 2023 Annual Report

Hong Kong Stock ExchangeApr 12 10:17 ET · Announcements

Neptune Interlon Announces 2023 Results Profit attributable to shareholders of 24.127 million, a year-on-year decrease of 55.6%

Neptune Interlon (08329) announced its 2023 results, with revenue of about 1,065 billion yuan, up about 7.92% year on year; profit attributable to company owners was 24.127 million yuan, a decrease of 55.6% year on year; profit per share was 1.44 points.

新浪港股Mar 27 20:54 ET

Neptune Interlon (08329) announced 2023 results. Profit attributable to owners of 24.127 million yuan decreased by 55.6% year-on-year

Neptune Interlon (08329) announced its 2023 results, with revenue of about 1,065 billion yuan, an increase of about 7.9 billion yuan over the previous year...

Zhitong FinanceMar 27 12:36 ET

NEP INTERLONG: ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED 31 DECEMBER 2023

Hong Kong Stock ExchangeMar 27 09:37 ET · Announcements

NEP INTERLONG: POSTPONEMENT OF DATE OF BOARD MEETING

Hong Kong Stock ExchangeMar 18 07:08 ET · Announcements

Neptune Interlon (08329) Fa Profit Alert expects annual profit attributable to shareholders to be reduced by more than 50%

According to the Zhitong Finance App, Neptune Interlon (08329) announced that it is expected that the profit attributable to company owners obtained by the Group for the year ended December 31, 2023 will be reduced by more than 50% compared to the same period in 2022. The main reason for this reduction was due to impairment losses in goodwill formed when the Group acquired Beijing Haiwang Zhongxin Pharmaceutical Co., Ltd.

Zhitong FinanceMar 15 07:15 ET

NEP INTERLONG: INSIDE INFORMATION ANNOUNCEMENTPROFIT WARNING

Hong Kong Stock ExchangeMar 15 07:09 ET · Announcements

Neptune Interlon (08329) and Neptune Easy Pharmaceutical signed a distribution agreement for 2023

According to the Zhitong Finance App, Neptune Interlon (08329) issued an announcement regarding the 2020 Neptune Star Consignment Agreement. Since the 2020 Neptune Star Consignment Agreement will expire on December 31, 2023, on December 28, 2023, the company and Neptune (a related party of the company) signed a 2023 consignment agreement. The Group will supply pharmaceuticals, food, health food and medical equipment to Easy Pharmaceutical Group for consignment sales in China. According to reports, these drugs (mainly including antibiotics, psychosomatic drugs, respiratory drugs, anti-allergy drugs and digestive drugs) and medical equipment are managed by the Group

Zhitong FinanceDec 28, 2023 04:52 ET

Neptune Intron announced the first three quarter results, profit attributable to owners of 45.56 million yuan, up 26.81% year on year

Neptune Intron (08329) announced results for the first three quarters of 2023, with revenue of approximately RMB 823 million, up 19.41% year on year; profit attributable to company owners of RMB 45.06 million, up 26.81% year on year; and earnings per share of 2.71 points.

新浪港股Nov 7, 2023 19:50 ET

NEP INTERLONG: THIRD QUARTERLY REPORT 2023

Hong Kong Stock ExchangeNov 7, 2023 06:12 ET · Announcements

Neptune Intron (08329) announced the first three quarter results, profit attributable to owners of 45.56 million yuan, up 26.81% year on year

According to the Zhitong Finance App, Haiwang Intron (08329) announced its results for the first three quarters of 2023, with revenue of approximately RMB 823 million, up 19.41% year on year; profit attributable to company owners of RMB 45.06 million, up 26.81% year on year; earnings per share of 2.71 points.

Zhitong FinanceNov 7, 2023 05:48 ET

NEP INTERLONG: ANNOUNCEMENT OF THIRD QUARTERLY RESULTS FOR THE NINE MONTHS ENDED 30 SEPTEMBER 2023

Hong Kong Stock ExchangeNov 7, 2023 05:45 ET · Announcements

Aquatic Interlon Announces Interim Results Shareholders' Profit of RMB 298.81 million, up 46.9% year-on-year

Neptune Interlon (08329) announced financial results for the six months ended June 30, 2023, with revenue of 555.5 million yuan (RMB, same below), up 26.6% year on year; shareholder profit of 298.81 million yuan, up 46.9% year on year; and basic profit of 1.78 points per share.

新浪港股Aug 13, 2023 20:20 ET

NEP INTERLONG: 2023 INTERIM REPORT

Hong Kong Stock ExchangeAug 11, 2023 07:58 ET · Announcements

NEP INTERLONG: ANNOUNCEMENT OF INTERIM RESULTS FOR THE SIX MONTHS ENDED 30 JUNE 2023

Hong Kong Stock ExchangeAug 11, 2023 07:55 ET · Announcements

NEP INTERLONG: FIRST QUARTERLY REPORT 2023

Hong Kong Stock ExchangeMay 8, 2023 06:47 ET · Announcements